Laboratory Corporation of America Holdings

Equities

LH

US50540R4092

Healthcare Facilities & Services

Real-time Estimate Cboe BZX 03:10:00 2024-04-25 pm EDT 5-day change 1st Jan Change
198.1 USD -4.75% Intraday chart for Laboratory Corporation of America Holdings -0.86% -13.01%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Leerink Partners Adjusts Laboratory Corp of America Price Target to $242 From $260, Keeps Outperform Rating MT
Laboratory Corp of America Q1 Adjusted Earnings, Revenue Increase; 2024 Adjusted EPS Outlook Updated MT
Transcript : Laboratory Corporation of America Holdings, Q1 2024 Earnings Call, Apr 25, 2024
Earnings Flash (LH) LABORATORY CORPORATION OF AMERICA HOLDINGS Reports Q1 Revenue $3.18B, vs. Street Est of $3.12B MT
Earnings Flash (LH) LABORATORY CORPORATION OF AMERICA HOLDINGS Reports Q1 EPS $3.68, vs. Street Est of $3.48 MT
Laboratory Corporation of America Holdings Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Labcorp beats quarterly estimates on strong testing demand RE
North American Morning Briefing : More Tech -2- DJ
Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln RE
Laboratory Corporation of America Holdings Announces Winning Bid for Select Assets of Invitae CI
Laboratory Corporation of America Holdings (NYSE:LH) won the bid to acquire substantially all of the assets of Invitae Corporation for approximately $240 million. CI
Laboratory Corporation of America Holdings (NYSE:LH) agreed to acquire Substantially all Assets of Invitae Corporation for approximately $240 million. CI
Labcorp Introduces Test for Early Detection of Neurodegenerative Diseases MT
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw CI
Labcorp Keeps Quarterly Dividend at $0.72 Per Share, Payable June 12 to Stockholders of Record May 28 MT
Labcorp Declares Quarterly Dividend, Payable on June 12, 2024 CI
Sector Update: Health Care Stocks Slump Wednesday Afternoon MT
Labcorp Says US FDA Granted Emergency Use Authorization for Mpox Home Collection Kit MT
Labcorp Gets Emergency Authorization from FDA for Home Kit to Detect Monkeypox DJ
Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit CI
Laboratory Corp of America Expands Precision Oncology Portfolio MT
Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs CI
Labcorp Launches Labcorp Plasma Detect? Extending Leadership into Molecular Residual Disease Clinical Research CI
Laboratory Corporation Receives a Shareholder Proposal from People for the Ethical Treatment of Animals CI
Laboratory Corporation Receives a Shareholder Proposal from Tara Health Foundation CI
Chart Laboratory Corporation of America Holdings
More charts
Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows: - clinical laboratory services (63.9%): routine testing, patient diagnosis, disease monitoring and treatment, and other services; - development and clinical trial services (36.1%): for pharmaceutical, biotechnology, medical device and diagnostic companies. Net sales are distributed geographically as follows : North America (81.2%), Europe (12.7%) and other (6.1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
207.9 USD
Average target price
243.8 USD
Spread / Average Target
+17.25%
Consensus
  1. Stock Market
  2. Equities
  3. LH Stock
  4. News Laboratory Corporation of America Holdings
  5. Laboratory Corp of America, ConcertAI Enter Collaboration to Optimize Precision Oncology Research